Jiang Zhong Pharmaceutical Co.,Ltd (SHSE:600750) agreed to acquire Jiangxi Jiang Zhong Changrun Pharmaceutical Co., Ltd./Jiangxi Jiang Zhong Changrun Pharmaceutical Co from Jiangxi Jiang Zhong Medicine Investment and Development Co., Ltd. for CNY13.5 million on November 25, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.35 CNY | -0.64% | -4.63% | +26.20% |
04-26 | Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-25 | Jiang Zhong Pharmaceutical Co.,Ltd Proposes Cash Dividend | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.20% | 2.28B | |
+37.77% | 705B | |
+32.82% | 583B | |
-3.60% | 364B | |
+20.35% | 332B | |
+5.30% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.60% | 169B |
- Stock Market
- Equities
- 600750 Stock
- News Jiang Zhong Pharmaceutical Co.,Ltd
- Jiang Zhong Pharmaceutical Co.,Ltd agreed to acquire Jiangxi Jiang Zhong Changrun Pharmaceutical Co., Ltd./Jiangxi Jiang Zhong Changrun Pharmaceutical Co from Jiangxi Jiang Zhong Medicine Investment and Development Co., Ltd. for CNY13.5 million.